Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Assessment of Volume-targeted Ventilation in Patients With Neuromuscular Disease

NCT: NCT06339580 · RECRUITING

NCT IDNCT06339580
StatusRECRUITING
Start Date2024-04-09
Completion2026-09-30
SponsorGuy's and St Thomas' NHS Foundation Trust (OTHER)
First posted
Last updated

Brief Summary

Assessment of safety and efficacy of volume-targeted ventilation in patients with neuromuscular disease.

Frequently Asked Questions

What is Assessment of Volume-targeted Ventilation in Patients With Neuromuscular Disease?

Assessment of Volume-targeted Ventilation in Patients With Neuromuscular Disease is a clinical trial registered under NCT06339580. Current status: RECRUITING.

What is the status of NCT06339580?

The current status of NCT06339580 (Assessment of Volume-targeted Ventilation in Patients With Neuromuscular Disease) is: RECRUITING.

When did Assessment of Volume-targeted Ventilation in Patients With Neuromuscular Disease start?

Assessment of Volume-targeted Ventilation in Patients With Neuromuscular Disease started on 2024-04-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑